Clinical Trial Update: A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 [Phase 1]

View source ↗

Summary

This first-in-human Phase 1 trial evaluates the safety, tolerability, and pharmacokinetics of GSK1399686 in inflammatory bowel diseases and has completed enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• GSK1399686

Snippet

Sponsor: GlaxoSmithKline | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: COMPLETED